Case
Pliva v. Mensing
10 published works
Drug & Device Law
A Recently Discovered Gem
We found a hidden (at least from us) Georgia federal court decision that we want to discuss because it hits on many of the effective defenses sometimes available to defendants…
Drug & Device Law
Guest Post – Design Defect Preemption – It’s as Simple as One, Two, Three
By Bexis
This guest post is from Richard Dean at Tucker Ellis. We're both greatly interested in extending impossibility preemption beyond generic drugs, particularly in the context of design defect claims, so…
Drug & Device Law
Breaking News – Innovators Ring The Bell In a Generic Case (And The Generics Do OK, Too)
By Bexis
This post, being about metoclopramide/Reglan, is from the ReedSmith side of the blog only. The Eighth Circuit decided branded and generic liability issues today in Bell v. Pfizer, Inc., No…
Drug & Device Law
NJ in Mainstream on Generic Preemption
By Bexis
We can't say much about it because of Dechert's involvement in the Reglan/metoclopramide litigation, but Judge Higbee has ruled on on generic preemption under Mensing. There are two opinions. The…
Drug & Device Law
More of the Same (But That’s A Good Thing)
We feel like we post on Mensing at least once a week and we have our quickly growing scorecard to back us up. It is not that surprising really, considering…
Drug & Device Law
Trying to Sanction Away Preemption (and Failing)
We always try to keep things lively around here. Law can sometimes be drudgery. But we don’t ever want that type of atmosphere to seep into this blog. That’s one…
Drug & Device Law
Generic Drug Preemption Q and A
By Bexis
There are now forty-eight post-Mensing generic drug preemption decisions on our scorecard, with more being decided on what seems like a weekly basis. Thus, the scorecard gets a little unwieldy…
Drug & Device Law
Putting It All Together
By Bexis
Our first reaction upon reading Metz v. Wyeth, 2012 U.S. Dist. Lexis 42432 (M.D. Fla. March 28, 2012), is boy, this case has a little of everything! After it was…
Defense Litigation Insider
Massachusetts Court Extends Mensing to Bar Failure To Warn Claims Against Generic Drug Distributors
Co-authored by Brian Gross In June of 2011, the United States Supreme Court ruled that makers of generic drugs cannot be sued for failing to warn consumers of the possible side…
Drug & Device Law
Not All Sunshine and Santa Claus For Generics Post-Mensing
When the Supreme Court decided Mensing, we imagine generic drug manufacturers felt like Stephen Sondheim’s “Everything’s Coming Up Roses” was written just for them. But, to borrow from another Broadway…